Document Detail


Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries.
MedLine Citation:
PMID:  20351559     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To document regional and global trends for patients retained on antiretroviral therapy (ART) 12-48 months after treatment initiation, in low-income and middle-income countries.
METHODS: Data reported by national programs to WHO/UNICEF/UNAIDS in 2008 were aggregated to produce regional and global estimates. The proportion of patients on ART at 12, 24, 36, and 48 months is derived from cohort monitoring systems in ART dispensing facilities.
RESULTS: Of 149 countries, 70 (47%) reported on retention at 12 months, 54 (36%) at 24 months, 38 (26%) at 36 months, and 30 (20%) at 48 months. Regional and global trends showed that the majority of attrition from ART programs occurred within the first year and declined thereafter. Among countries in sub-Saharan Africa, retention on ART was estimated at 75.2% at 12 months, 66.8% at 24 months, and remained at a similar level up to 48 months.
CONCLUSIONS: After high attrition in the first year, retention on ART tends to stabilize. In the literature, attrition in the first year was related to early mortality. Earlier presentation for diagnosis of HIV infection, timely screening, and access to ART are fundamental to reduce it. Countries need support in reporting on outcomes on ART.
Authors:
Jean-Michel Tassie; Parijat Baijal; Marco A Vitoria; Abdikamal Alisalad; Siobhan P Crowley; Yves Souteyrand
Related Documents :
19717249 - Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.
18706769 - Relapse to smoking after 1 year of abstinence: a meta-analysis.
23613639 - Endoscopic papillary balloon intermittent dilatation and endoscopic sphincterotomy for ...
23519549 - Anastomotic strictures and endoscopic dilatations following esophageal atresia repair.
23521469 - Percutaneous bilateral metallic stent placement using a stentin-stent deployment techni...
22286429 - Fourth-dimensional changes in nasolabial dimensions following rotation-advancement repa...
10193839 - Does intensive perioperative dialysis improve the results of coronary artery bypass gra...
20462329 - Arteriovenous haemangioma in liver disease. treatment with carbon dioxide laser vaporiz...
19717249 - Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  54     ISSN:  1944-7884     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-08     Completed Date:  2010-08-10     Revised Date:  2011-09-06    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  437-41     Citation Subset:  IM; X    
Affiliation:
Department of HIV/AIDS, World Health Organization, Geneva, Switzerland. tassiej@who.int
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acquired Immunodeficiency Syndrome / economics,  prevention & control*
Africa South of the Sahara
Anti-HIV Agents / economics*,  therapeutic use*
Antiretroviral Therapy, Highly Active / economics*
Asia
Caribbean Region
Europe
Follow-Up Studies
Income
Middle East
Poverty
Time Factors
Chemical
Reg. No./Substance:
0/Anti-HIV Agents
Comments/Corrections
Comment In:
J Acquir Immune Defic Syndr. 2011 Mar;56(3):e102; author reply e102-3   [PMID:  21317578 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of highly active antiretroviral therapy on homocysteine plasma concentrations in HIV-1-infect...
Next Document:  Ameliorative Role of Rosiglitazone in Hyperhomocysteinemia-Induced Experimental Cardiac Hypertrophy.